NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
Provided By PR Newswire
Last update: Mar 6, 2025
NEW YORK, March 6, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the "Class Period"), of the important March 25, 2025 lead plaintiff deadline.
Read more at prnewswire.com87.17
-0.87 (-0.99%)
Find more stocks in the Stock Screener
NVO Latest News and Analysis
5 days ago - ChartmillInvestors should take note of NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO), a growth stock that remains attractively priced.Uncover the potential of NOVO-NORDISK A/S-SPONS ADR, a growth stock reasonably priced. NYSE:NVO is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation.
